Abstract:Although frequently seen as an early complication of OHT, SND remains a risk throughout the lifetime of OHT recipients. Its mechanism is likely multifactorial, and whether this risk can be mitigated over the long term by newer techniques such as bicaval anastamoses remains to be established.
“…Unfortunately, we were unable to determine the interaction between ischemic time and donor and recipient age, as multivariate analyses were not feasible with the small number of cases in this study. We also found no association between late‐onset AV block and acute cellular rejection and CAV, as reported by other studies 6,13 . Hence, although we were unable to identify the mechanism of late‐onset AV block, late‐onset SND and AV block appears unlikely to be related to surgical trauma 13 …”
Section: Discussionsupporting
confidence: 77%
“…Some studies suggested late‐onset SND and others AV block as the dominant indication for permanent pacing, although the number of patients were generally small (Table III). 4 , 7–11 , 13–16 This study, with 27 patients who required permanent pacing >3 months from heart transplant (13 [48.2%] due to SND and 14 [51.8%] due to AV block) add to these previous reports and suggest that both SND and AV block may contribute equally to the need for permanent pacing late after heart transplantation.…”
Section: Discussionsupporting
confidence: 51%
“…Our data are consistent with other studies of late‐onset heart block in orthotopic transplantation (ranging from 1.0% to 3.2%), with time to permanent pacemaker implantation ranging from 6 to 122 months (Table III). 4 , 6–14 …”
Section: Discussionmentioning
confidence: 99%
“…Our data are consistent with other studies of late-onset heart block in orthotopic transplantation (ranging from 1.0% to 3.2%), with time to permanent pacemaker implantation ranging from 6 to 122 months (Table III). 4,[6][7][8][9][10][11][12][13][14] Some studies suggested late-onset SND and others AV block as the dominant indication for permanent pacing, although the number of patients were generally small (Table III). 4,[7][8][9][10][11][13][14][15][16] This study, with 27 patients who required permanent pacing >3 months from heart transplant (13 [48.2%] due to SND and 14 [51.8%] due to AV block) add to these previous reports and suggest that both SND and AV block may contribute equally to the need for permanent pacing late after heart transplantation.…”
Late-onset AV block occurs in 2.4% of patients with orthotopic heart transplant or heart-lung transplant. AV block is predominantly intermittent and, often, does not progress to permanent AV block. There are no predictable factors for its onset.
“…Unfortunately, we were unable to determine the interaction between ischemic time and donor and recipient age, as multivariate analyses were not feasible with the small number of cases in this study. We also found no association between late‐onset AV block and acute cellular rejection and CAV, as reported by other studies 6,13 . Hence, although we were unable to identify the mechanism of late‐onset AV block, late‐onset SND and AV block appears unlikely to be related to surgical trauma 13 …”
Section: Discussionsupporting
confidence: 77%
“…Some studies suggested late‐onset SND and others AV block as the dominant indication for permanent pacing, although the number of patients were generally small (Table III). 4 , 7–11 , 13–16 This study, with 27 patients who required permanent pacing >3 months from heart transplant (13 [48.2%] due to SND and 14 [51.8%] due to AV block) add to these previous reports and suggest that both SND and AV block may contribute equally to the need for permanent pacing late after heart transplantation.…”
Section: Discussionsupporting
confidence: 51%
“…Our data are consistent with other studies of late‐onset heart block in orthotopic transplantation (ranging from 1.0% to 3.2%), with time to permanent pacemaker implantation ranging from 6 to 122 months (Table III). 4 , 6–14 …”
Section: Discussionmentioning
confidence: 99%
“…Our data are consistent with other studies of late-onset heart block in orthotopic transplantation (ranging from 1.0% to 3.2%), with time to permanent pacemaker implantation ranging from 6 to 122 months (Table III). 4,[6][7][8][9][10][11][12][13][14] Some studies suggested late-onset SND and others AV block as the dominant indication for permanent pacing, although the number of patients were generally small (Table III). 4,[7][8][9][10][11][13][14][15][16] This study, with 27 patients who required permanent pacing >3 months from heart transplant (13 [48.2%] due to SND and 14 [51.8%] due to AV block) add to these previous reports and suggest that both SND and AV block may contribute equally to the need for permanent pacing late after heart transplantation.…”
Late-onset AV block occurs in 2.4% of patients with orthotopic heart transplant or heart-lung transplant. AV block is predominantly intermittent and, often, does not progress to permanent AV block. There are no predictable factors for its onset.
“…It is interesting to note that most patients developing SND required their pacemaker within the first 80 days (104 patients, 88%) while only 14 patients required pacemakers later. Luebbert et al presented data showing that in their post‐transplant SND cohort, 58% of the patients required a pacemaker within the first 30 days—in our study, 54% of the patients had received their pacemaker for post‐transplant SND within the first 30 days. A graphical representation of the time of pacemaker implantation in our cohort is shown in Figure .…”
We identified the biatrial anastomosis and a low ratio of reperfusion time to aortic cross-clamp time as well as to ischemia time as risk factors for SND requiring pacing. After implantation pacemakers continue to pace for over 60% of the time after 6 years.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.